Sweden launches testbed for clinical trials in cancer care

Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient organizations to create an innovation milieu that facilitates the introduction of more precise prevention...

Precision medicine new opportunity for complex diseases

New review article looks at readiness prior to the implementation of genomics-based precision medicine in complex diseases. The extensive work has been led by researchers at Karolinska Institutet and Lund University and has been carried out together with some 30...

GMS’s ambitions for the next 10 years

Genomic Medicine Sweden (GMS) highlights vital aspects for the successful introduction of precision medicine into Swedish healthcare in its Strategy Plan 2021–2030. In Strategy Plan 2021–2030, GMS presents its ambitions for the introduction of precision medicine into...